Clinical Trial Update: Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing oral PF-06651600, PF-06700841, and placebo in moderate to severe ulcerative colitis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• PF-06651600 (PF-06651600)
• PF-06700841

Snippet

Sponsor: Pfizer | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2022-07-21